Intellia Therapeutics, Inc. (NTLA) Stock Price History
Historical prices from 2016 to 2026
Loading 10-year price history...
NTLA Historical Performance
Short-Term Returns
NTLA Stock Price Trajectory (2016–2026)
As of May 8, 2026, Intellia Therapeutics, Inc. (NTLA) trades at $14.09, representing a +70.2% return over the past year. The stock has delivered a -76.9% total return over five years (-25.4% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $202.73 on June 30, 2021. From this peak, NTLA has corrected -93.0%, currently trading 7% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers EDIT (+123.7% 1Y), CRSP (+51.7% 1Y), and BEAM (+87.4% 1Y), NTLA has underperformed the peer group average. Compare NTLA vs EDIT →
NTLA Historical Price Data (2025–2026)
Showing 30 of 2,517 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-08 | 14.01 | 14.55 | 13.73 | 14.09 | 5.71M | +2.77% |
| 2026-05-07 | 13.78 | 14.06 | 13.41 | 13.71 | 3.88M | -1.01% |
| 2026-05-06 | 13.25 | 13.88 | 13.11 | 13.85 | 3.74M | +4.06% |
| 2026-05-05 | 14.11 | 14.33 | 13.20 | 13.31 | 4.83M | -4.04% |
| 2026-05-04 | 13.31 | 14.07 | 13.31 | 13.87 | 6.44M | +4.60% |
| 2026-05-01 | 13.27 | 13.54 | 12.80 | 13.26 | 5.74M | -1.63% |
| 2026-04-30 | 12.62 | 14.06 | 12.62 | 13.48 | 12.82M | +8.32% |
| 2026-04-29 | 12.15 | 12.95 | 11.76 | 12.45 | 26.60M | -5.72% |
| 2026-04-28 | 12.81 | 14.16 | 12.72 | 13.20 | 14.93M | +1.23% |
| 2026-04-27 | 14.23 | 14.75 | 12.39 | 13.04 | 27.18M | -4.33% |
| 2026-04-24 | 15.89 | 16.04 | 13.42 | 13.63 | 7.78M | -14.11% |
| 2026-04-23 | 16.80 | 16.97 | 15.57 | 15.87 | 5.40M | -4.22% |
| 2026-04-22 | 15.71 | 16.58 | 15.65 | 16.57 | 3.69M | +8.23% |
| 2026-04-21 | 15.45 | 15.91 | 15.22 | 15.31 | 4.29M | +0.66% |
| 2026-04-20 | 14.76 | 15.30 | 14.53 | 15.21 | 2.62M | +1.74% |
| 2026-04-17 | 14.58 | 15.14 | 14.49 | 14.95 | 3.05M | +5.58% |
| 2026-04-16 | 14.95 | 14.97 | 13.88 | 14.16 | 3.60M | -5.22% |
| 2026-04-15 | 15.04 | 15.28 | 14.46 | 14.94 | 2.66M | +1.08% |
| 2026-04-14 | 14.59 | 15.15 | 14.35 | 14.78 | 2.93M | +3.65% |
| 2026-04-13 | 13.37 | 14.47 | 13.30 | 14.26 | 3.27M | +5.71% |
| 2026-04-10 | 13.87 | 13.89 | 13.28 | 13.49 | 1.71M | -2.46% |
| 2026-04-09 | 13.72 | 13.98 | 13.62 | 13.83 | 1.38M | -0.29% |
| 2026-04-08 | 14.44 | 14.49 | 13.57 | 13.87 | 3.01M | +2.36% |
| 2026-04-07 | 13.20 | 13.56 | 12.85 | 13.55 | 2.16M | +1.88% |
| 2026-04-06 | 13.31 | 13.72 | 13.17 | 13.30 | 1.91M | +1.29% |
| 2026-04-02 | 12.75 | 13.27 | 12.47 | 13.13 | 2.72M | -1.06% |
| 2026-04-01 | 12.97 | 13.65 | 12.95 | 13.27 | 3.02M | +3.51% |
| 2026-03-31 | 11.87 | 12.99 | 11.87 | 12.82 | 4.16M | +10.04% |
| 2026-03-30 | 12.31 | 12.36 | 11.62 | 11.65 | 3.47M | -5.82% |
| 2026-03-27 | 13.12 | 13.16 | 12.12 | 12.37 | 3.72M | -6.57% |
See NTLA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NTLA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NTLA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNTLA — Frequently Asked Questions
Quick answers to the most common questions about buying NTLA stock.
How has NTLA stock performed recently?
NTLA returned +70.2% over the past year, beating its 5-year annualized CAGR of -25.4%. The stock trades above its 200-day moving average, confirming the uptrend.
What is NTLA's all-time high price?
Intellia Therapeutics, Inc. reached $202.73 on 2021-06-30. The 52-week high is $28.25. Current 1-year return of +70.2% places the stock closer to historical peaks.
Where can I download NTLA historical price data?
This page provides NTLA daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2016-2026, downloadable in CSV format.